Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever

NCT00237016 is registered in ClinicalTrials.gov with Medical Corps, Israel Defense Force as lead sponsor.

NCT NCT00237016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00237016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever
Lead sponsor
Medical Corps, Israel Defense Force
Phase
Phase 2/3
Overall status
Completed
Start date
April 30, 2002
Completion date
April 30, 2003
Enrollment
140
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

jarisch herxheimer reaction, relapsing fever, tick-borne